Qilong Zhang

发表论文 12 篇 · 总被引 581 次 · h-index 6

代表论文

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432 (2019 · Annals of Oncology · 被引 480)
LBA11 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial (2023 · Annals of Oncology · 被引 42)
Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study (2017 · European Journal of Cancer Care · 被引 18)
LBA16 Dalpiciclib plus letrozole or anastrozole as first-line treatment for HR+/HER2- advanced breast cancer (DAWNA-2): A phase III trial (2022 · Annals of Oncology · 被引 15)
Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC (2023 · Heliyon · 被引 10)
ATP2C2 as a novel immune-related marker that defines the tumor microenvironment in triple-negative breast cancer (2023 · Translational Cancer Research · 被引 9)